| Date Filed | Type | Description |
| 08/10/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/12/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/09/2023 |
4
| Third Rock Ventures IV, L.P. (10% Owner) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Sold 2,200,000 shares
@ $0.83, valued at
$1.8M
Sold 1,500,000 shares
@ $0.82, valued at
$1.2M
|
|
| 11/03/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/10/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/05/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/11/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 11/06/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/07/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2020 |
4
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Converted 5,559,440 shares
@ $0
Converted 2,132,867 shares
@ $0
Converted 39,750,000 preferred shares
@ $0
Converted 15,250,000 preferred shares
@ $0 |
|
| 06/02/2020 |
3
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 3 on PLIANT THERAPEUTICS, INC. |
| 05/11/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/05/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/04/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/06/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/22/2019 |
4
| Third Rock Ventures IV, L.P. (10% Owner) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Converted 2,261,904 shares
@ $0
Bought 81,250 shares
@ $16, valued at
$1.3M
Converted 15,833,333 preferred shares
@ $0 |
|
| 07/17/2019 |
3
| Third Rock Ventures IV, L.P. (10% Owner) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 05/03/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/28/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/27/2018 |
4
| Third Rock Ventures IV, L.P. (10% Owner) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Converted 7,911,455 shares
@ $0
Converted 20,102,478 preferred shares
@ $0
Converted 340,566 preferred shares
@ $0 |
|
| 06/20/2018 |
3
| Third Rock Ventures IV, L.P. (10% Owner) has filed a Form 3 on Magenta Therapeutics, Inc. |